Compounds Screening/Testing TRIZ Cases

Pre-introducing mutant tau protein compresses pathology onset to eight months, reducing maintenance costs and study duration.

Recombinant mammalian cell lines produce glyco-modified viral antigens with simplified human liver-like glycosylation patterns.

Sublingual drops target dendritic cells to identify delayed food allergies, resolving the trade-off between diagnostic accuracy and patient comfort.

Generates pure brown adipose tissue from stem cells without cell sorting or genetic manipulation, resolving process complexity.

Using pigs and guinea pigs for first- and second-degree block assessment predicts drug-induced arrhythmia risks during non-clinical trials.

18F-radiolabeled c-Met binding cyclic peptides enable non-invasive PET imaging of tumor expression levels.

Heterozygous knock-in mice expressing mutant TDP-43 at endogenous levels resolve expression control issues found in overexpression models.

A CD8+ T cell subpopulation analysis method predicts spinal fusion non-union probability using immunological biomarkers.

Renal clearable nanoparticles serve as exogenous markers to evaluate kidney function through blood or urine sample analysis.

A CD19 CAR-T cell animal model simulates cytokine release syndrome in leukemia treatment.

A breath test using isotope-labeled glucose measures carbon dioxide ratios in expired air to assess metabolic function.

Adult epithelial stem cells enable rapid generation of specific cancer-bearing animal models.

Engineered immunodeficient mice expressing human SIRPα and CD47 replicate tumor microenvironments, resolving the accuracy gap in preclinical drug screening.

Electric organ discharge monitoring evaluates anesthetic effects on neural oscillators, reducing device complexity and cost.

Combined BCG and pertussis toxin induction reduces costs while extending depression-like behaviors for stable animal models.

Compound 1 treats postpartum depression while minimizing infant exposure through breast milk via adjusted dosing and monitoring.

HIF-2α-specific radioactive tracers enable positron emission tomography detection of hypoxic tumors without invasive biopsy procedures.

A Tmax metric identifies maximum 13CO2 excretion time in gastric emptying breath tests to improve diagnostic precision.

Intermediary antibodies block PACAP-induced neuronal activation, reducing migraine pain without the adverse effects of triptans or NSAIDs.

Fluorescent activated cell sorting isolates single B cells to generate high-affinity monoclonal antibodies that block allergen interactions and reduce symptoms.

Inserts hp7 sequence and poly A signal into mouse genome to stabilize foreign gene mRNA expression.

Chick models replace costly rodents, using distress vocalizations to differentiate drug effects while reducing screening expenses.

A skin heating device applies controlled thermal energy to increase epidermal permeability for faster antigen uptake.

Deleting the DNA-binding Neh1 domain eliminates background transcriptional noise, enabling specific monitoring of oxidative stress in individual organs.

Introducing negative charges at positions 49-56 in the CDR2 region enhances aggregation resistance while maintaining antigen binding affinity.

Radiolabeled Apelin targets APJ receptors to resolve poor VEGFR discrimination in angiogenesis imaging.

Removing self-immolative spacers from antibody-drug conjugate linkers simplifies structure while maintaining targeted drug release efficiency.

Low thujone Salvia officinalis extract delays epigenetic aging modifications to treat age-related pathologies.